CD274 and breast carcinoma: Interestingly, gene silencing of moesin has been reported to remarkably decrease the plasma membrane localization of PD-L1 in human breast cancer, indicating a novel regulatory mechanism by which moesin modulates the protein expression levels of PD-L1 via post-translational modification [40].